Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Obesity × Docosahexaenoic Acids × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1 Lipid Metabolism Disorders 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Metformin 2 rosiglitazone-metformin combination 1 mirabegron 1 exemestane 1 atezolizumab 1 Tirzepatide 1 TIC10 compound 1 Rosiglitazone 1 Hydroquinones 1 Fish Oils 1 Docosahexaenoic Acids 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡